Over the last decade mild to moderate hyperhomocysteinaemia has become an established risk factor for premature vascular disease.t-' and more recently for obstetric complications such as recurrent miscarriage, gross placental infarcts and neural tube defects." In addition, the determination of total homocysteine in plasma is used for the diagnosis and follow-up of folate and cobalamin deficiencies as well as the rare inborn errors of cobalamin metabolism, cystathionine synthase and methylene-tetrahydrofolate reductase deficiency. ' The increasing interest in the determination of total homocysteine in plasma has led to the development of several different methods. This paper concerns three methods, one using a conventional amino acid analyser" and the other two high-pressure liquid chromatography (HPlC).~,6
MATERIALS AND METHODS
The amino acid analyser method (Alpha-Plus, Pharmacia/lKB) used dithiotreitol for the reduction of disulphide bonds, and post-column derivatization with ninhydrin, essentiallyaccording to Andersson et al. 4 The column was equilibrated with O·6 mol/L lithium citrate, pH 3· 02 for 45 min. Next a buffer containing 1·0 mol/L lithium citrate, pH 3·45 eluted respectively homocysteine, methionine and norleucine ( The total homocysteine concentration is 40· 0 I'm011L. Peaks: 1 = cysteine, 2 = cysteinylglycine, 3 = homocysteine, 4 = cysteamine. (c) HPLC chromatogram of SBD-F derivatized thiols in a pooled plasma. The total homocysteine concentration is 40-0/LmoIlL. Peaks:
from the ion exchange column (272 mm, ID 4· 6 mm and 6 I'm particle size) with a flow rate of 0·3 mL/min. To 0·15 mL of thawed plasma, 0·15 mL dithiotreitol (40 mM; pH 9,0) was added, mixed and incubated for 10 min at room temperature. The mixture was deproteinized by adding 0'15 mL of a sulphosalicyclic acid solution (25% w/v) containing L-norleucine (306 /Lmol/L) as an external standard. After vortexing, the mixture was kept on ice for 10 min and then centrifuged at 3500 g for 10 min. The supernatant was filtered (0'45 JLm, Millipore) just before analysis. The absorption intensities of ninhydrin derivatives were measured at 440 and 570 nm. The HPLC sodium borohydride/monobromobimane (NaBH 4/mBrB method used NaBH 4 for reduction and mBrB for derivatization essentially according to Fiskerstrand et al. 5 with cysteamine as external standard. A programmable sample processor (Gilson model 232 BID, Dilutor 401) was used for automated homocysteine reduction, derivatization and sample injection. After equilibration with 30 mmollL ammonium nitrate, 40 mmollL ammonium formate and 4 mmollL tetra-n-butylammonium hydrogen sulphate (pH 3· 2), the thiol derivatives were eluted from the column (Supelcosil LC-I8 15 em, 4·6 mm, 3 JLm) with a 0 to 10· 5070 acetonitrile gradient in 11 min with a flow rate of 1 mL/min (Fig. lb) ,
The HPLC tributylphosphine/ammonium 7fluorobenzo-2-oxa-I,3-diazide-4-sulphonate (fBP/ SBD-F) method applied TBP for reduction and SBD-F as derivatization agent according to Ubbink et al. 6 with some modifications. For derivatization 100 JLL of plasma and 50 JLL of internal standard (cysteamine 0·125 mM) were mixed with 15 JLL 10% TBP in methylformamide and incubated for 30 min at 4°C. The solution was deproteinized with 0'15 mL 10% trichloroacetic acid containing 1 mmollL Na 4EDT A under vortexing, followed by centrifugation at 10 min at 4000 g. A 50 JLL aliquot of the clear supernatant was mixed with 15 JLL of sodium hydroxide (1' 55 moIlL), 125 JLL borate buffer (0'125 mollL), pH 9·5 containing 4 mmollL EDTA, and 50 JLL SBD-F (1 mg/mL dissolved in borate buffer) and incubated for 60 min at 60°C. The sample was diluted with eluent (1:5) and 20 JLL of the mixture was injected. The SBD-F derivatives were eluted isocratically from the column by 0·1 M KH 2P04/5% acetonitril (pH 2,15) with a flow rate of 1 mL/min (Fig. Ie) .
EDT A plasma samples, not spiked, of controls and of vascular patients with severe or mild hyperhomocysteinaemia were used for correlation studies.
RESULTS AND DISCUSSION
The detection limits of all three methods were low (< O' 5 mollL) and only small amounts (less than 150 JLL) of plasma were required for good reproducibility. The inter-and intra-run coefficients of variation were less than 6· 5%.
A disadvantage of the amino acid analyser method was the long injection to injection time of 138 min compared to 20 min or less for the
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HPLC methods. On the other hand, the amino acid analyser method also measured other amino acids involved in homocysteine metabolism such as methionine, cystathionine and cysteine. A disadvantage of both the amino acid analyser and the HPLC TBP/SBD-F methods was that they were not fully automated whereas the HPLC NaBH4/mBrB method was fully automated for unattended analysis of 105 samples. The least squares regressionequation between the HPLC NaBH4/mBrB method (x) and the amino acid analyser (y) wasy=O·72+ I'07x, (r=0'985, n = 80). The total homocysteine concentrations (free and protein bound) in the plasma of controls and patients varied from 4-156 JLmollL. The regression equation between the HPLC NaBH4/ mBrB X method (x) and the HPLC TBP/SBD-F method (y) was y=0·I4+I·04 x (r=0'99I, n = 37), and the total homocysteine concentrations in plasma of controls and patients varied from 9-173 JLmollL. The equation between the different methods shows that, despite the use of different kinds of reducing agents, similar amounts of total homocysteine are recovered from the plasma.
The HPLC NaBH4/mBrB method was modified and improved by using: (1) cysteamine as an external standard whereas Fiskerstrand et al? used no standard; (2) addition of tetrabutylammonium hydrogen sulphate to the mobile phase for improvement of separation of the homocysteine peak from the fluorescent side products of mBrB; (3) reducing the flow rate from 1· 5 mL/ min to 1· 0 mL/min; (4) increasing the total capacity for unattended analysis from 60-105 samples. Therefore, this method is preferable for measurements of large numbers of samples. The HPLC TBP/SBD-F method" was modified by reducing volumes to economize the use of samples and reagents during derivatization and the use of cysteamine as internal standard.
In conclusion, all three methods studied are appropriate for the diagnosis of mild and severe hyperhomocysteinaemia or cobalamin/folate deficiency in a routine laboratory setting.
